Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.37 |
| ▸ | PPARG | P37231 | 6/20 | 0.37 |
| ▸ | PPARD | Q03181 | 6/20 | 0.37 |
| ▸ | PPARA | Q07869 | 6/20 | 0.37 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.37 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | TLR2 | O60603 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | FABP4 | P15090 | 2/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.37 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.37 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2207815 | 0.93 | FDPS (0.43) | FDPSALDH1A1AKR1B1ALOX15GPR84 | |
| SCHEMBL8464966 | 0.91 | SMPD1 (0.45) | FDPSALDH1A1ALOX15GPR84PPARG | |
| SCHEMBL7617795 | 0.91 | SMPD1 (0.45) | FDPSALDH1A1ALOX15GPR84PPARG | |
| SCHEMBL249486 | 0.91 | SMPD1 (0.45) | FDPSALDH1A1ALOX15GPR84PPARG | |
| SCHEMBL3284980 | 0.91 | SMPD1 (0.45) | FDPSALDH1A1ALOX15GPR84PPARG | |
| SCHEMBL8466412 | 0.91 | SMPD1 (0.45) | FDPSALDH1A1ALOX15GPR84PPARG | |
| SCHEMBL658156 | 0.91 | SMPD1 (0.45) | FDPSALDH1A1ALOX15GPR84PPARG | |
| SCHEMBL7619946 | 0.91 | SMPD1 (0.45) | FDPSALDH1A1ALOX15GPR84PPARG | |
| SCHEMBL7623878 | 0.91 | SMPD1 (0.45) | FDPSALDH1A1ALOX15GPR84PPARG | |
| Ammonia Solution, Strong SCHEMBL28996637 | 0.89 | SMPD1 (0.44) | FDPSALDH1A1ALOX15GPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9283199-B2 | Halogenated aliphatic carboxylic acids, oligomers and/or polymers thereof and their use in devitalizing external and internal neoplasms | CIMAS LIMITED (CY) | 2016-03-15 | — | — | US | disclosed |
| US-20160067198-A1 | HALOGENATED ALIPHATIC CARBOXYLIC ACIDS, OLIGOMERS AND/OR POLYMERS THEREOF AND THEIR USE IN DEVITALIZING EXTERNAL AND INTERNAL NEOPLASMS | CIMAS LIMITED (CY) | 2016-03-10 | — | — | US | disclosed |
| CN-101564925-B | High barrier laminated body | MITSUBISHI GAS CHEMICAL CO | 2014-03-19 | — | — | CN | disclosed |
| EP-1603932-B1 | METHODS AND COMPOSITIONS FOR THE ENZYMATIC SYNTHESIS OF GANGLIOSIDES | SENEB BIOSCIENCES INC (US) | 2012-10-03 | — | — | EP | disclosed |
| CN-102695503-A | Halogenated aliphatic carboxylic acids, oligomers and/or polymers thereof and their use for inactivating external and internal neoplasias | MARDI MEDICINES LTD | 2012-09-26 | — | — | CN | disclosed |
| EP-2440198-A2 | HALOGENATED ALIPHATIC CARBOXYLIC ACIDS, OLIGOMERS AND/OR POLYMERS THEREOF AND THEIR USE IN DEVITALIZING EXTERNAL AND INTERNAL NEOPLASMS | Mardi Medicines Ltd. (IL) | 2012-04-18 | — | — | EP | disclosed |
| US-20110052641-A1 | HALOGENATED ALIPHATIC CARBOXYLIC ACIDS, OLIGOMERS AND/OR POLYMERS THEREOF AND THEIR USE IN DEVITALIZING EXTERNAL AND INTERNAL NEOPLASMS | MARDI MEDICINES LTD. (IL) | 2011-03-03 | — | — | US | disclosed |
| US-7888331-B2 | Ganglioside compositions and methods of use | SENEB BIOSCIENCES, INC. (US) | 2011-02-15 | — | — | US | disclosed |
| WO-2010143188-A2 | HALOGENATED ALIPHATIC CARBOXYLIC ACIDS, OLIGOMERS AND/OR POLYMERS THEREOF AND THEIR USE IN DEVITALIZING EXTERNAL AND INTERNAL NEOPLASMS | MARDI MEDICINES LTD. (IL) | 2010-12-16 | — | — | WO | disclosed |
| CN-101564925-A | High barrier laminated body | MITSUBISHI GAS CHEMICAL CO (JP) | 2009-10-28 | — | — | CN | disclosed |
| US-5519007-A | ENZYME INHIBITORS OF KINASES FOR NERVOUS SYSTEM INHIBITORS | FIDIA, S.P.A. (IT) | 1996-05-21 | — | — | US | disclosed |
| EP-0373039-B1 | New lysoganglioside derivatives | FIDIA SPA (IT) | 1994-04-06 | — | — | EP | disclosed |
| EP-0410883-A2 | Di-lysogangliosides derivatives | FIDIA S.p.A. (IT) | 1991-01-30 | — | — | EP | disclosed |
| EP-0208617-B1 | CONTROLLED DRUG DEVICE AND PROCESS FOR CATALYSING THE EROSION OF AN ACID LABILE POLYMER | MERCK & CO. INC. (US) | 1990-09-26 | — | — | EP | disclosed |
| EP-0373038-A2 | New lysosphingolipid derivatives | FIDIA S.p.A. (IT) | 1990-06-13 | — | — | EP | disclosed |
| EP-0373039-A2 | New lysoganglioside derivatives | FIDIA S.p.A. (IT) | 1990-06-13 | — | — | EP | disclosed |
| EP-0208617-A1 | Controlled drug device and process for catalysing the erosion of an acid labile polymer | MERCK & CO. INC. (US) | 1987-01-14 | — | — | EP | disclosed |
| US-4076911-A | PALLADIUM CYANIDE CATALYST | UNION OIL COMPANY OF CALIFORNIA (US) | 1978-02-28 | — | — | US | disclosed |
| US-4009203-A | REACTION PRODUCT OF TIN HALIDE WITH A CARBOXYLIC ACID AS CATALYST | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1977-02-22 | — | — | US | disclosed |
| US-4007222-A | Process for the production of 2-chlorocaproic acids | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1977-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160067198-A1 | HALOGENATED ALIPHATIC CARBOXYLIC ACIDS, OLIGOMERS AND/OR POLYMERS THEREOF AND THEIR USE IN DEVITALIZING EXTERNAL AND INTERNAL NEOPLASMS | CCR10, PBK, CCR3 | FDPS 3090/4885ALDH1A1 1008/4885AKR1B1 1741/4885 |
| US-20110052641-A1 | HALOGENATED ALIPHATIC CARBOXYLIC ACIDS, OLIGOMERS AND/OR POLYMERS THEREOF AND THEIR USE IN DEVITALIZING EXTERNAL AND INTERNAL NEOPLASMS | CCR10, PBK, CCR3 | FDPS 3090/4885ALDH1A1 1008/4885AKR1B1 1741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.